January 22, 2012
Fitch Even partner Kendrew H. Colton was quoted in an article published in the December 17, 2012, online and print editions of Chemical & Engineering News, a weekly publication of the American Chemical Society. The article, titled "Protest Over U.S. Price of AIDS Drug," discusses the response expected from the National Institutes of Health (NIH) to a petition asking NIH to override Abbott Laboratories’ patents on the AIDS drug, Norvir, and allow generic production to lower the drug’s cost.
Ken has extensive intellectual property counseling and litigation experience involving patent infringement, contract licensing disputes, copyrights, unfair competition, and trade secrets. His practice specialty is designing strategies to achieve market exclusivity and freedom to operate for clients in established and emerging chemical and biochemical technologies.
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more